In a patient with acute unilateral right visual loss due to optic neuritis and MRI showing enhancement of the extraocular muscles and the intracanalicular segment of the optic nerve, what is the most likely diagnosis?

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

The combination of acute unilateral optic neuritis with enhancement of both the intracanalicular optic nerve AND extraocular muscles on MRI is highly suggestive of MOGAD, which should be the primary diagnostic consideration in this patient. 1

Key Diagnostic Features Supporting MOGAD

The imaging pattern described is particularly distinctive:

• Optic nerve sheath and perioptic enhancement is more distinctive of MOGAD compared to other demyelinating conditions 1
• The involvement of extraocular muscles alongside optic nerve enhancement creates a pattern consistent with orbital inflammation that extends beyond the nerve itself
• MOGAD characteristically shows anterior optic nerve involvement (which includes the intracanalicular segment) 1
• A case report directly describes this exact presentation: a patient with MOGAD presenting with unilateral optic nerve enhancement in the intraorbital and intracanalicular segments with surrounding fat stranding and orbital apex involvement 2

Differential Diagnosis Framework

While MOGAD is most likely, consider this hierarchy:

Primary Consideration: MOGAD

• Optic nerve sheath and perioptic enhancement pattern
• Extraocular muscle involvement suggests broader orbital inflammation
• Typically unilateral in acute presentation
• Requires serum anti-MOG antibody testing for confirmation 2

Alternative Possibilities (Less Likely Given Imaging):

Multiple Sclerosis (MS):

• Characteristically shows shorter segment unilateral optic nerve involvement 1
• Does NOT typically involve extraocular muscles
• Enhancement pattern usually confined to the nerve itself without perioptic spread

Neuromyelitis Optica (NMO):

• Tends toward posterior optic nerves, chiasm, or tracts rather than anterior/intracanalicular segments 1
• Less likely to show isolated anterior involvement with extraocular muscle enhancement

Idiopathic Orbital Inflammation/Optic Perineuritis:

• Could explain extraocular muscle involvement
• May be secondary to autoimmune or infectious etiologies 1
• Patients tend to be older and may have central vision sparing 1

Critical Next Steps

Immediate Serological Testing:

• Anti-MOG antibodies (cell-based assay is gold standard)
• Anti-AQP4 antibodies to exclude NMO spectrum disorder
• These antibody tests are now considered key tools for definitive diagnosis 3

Additional MRI Evaluation:

• Complete brain and spine MRI with contrast to assess for additional demyelinating lesions 1, 4
• This helps differentiate between MOGAD, MS, and NMO based on lesion distribution patterns
• Detection of asymptomatic optic nerve or brain lesions aids in distinguishing these conditions 1

Treatment Implications

The distinction matters critically for management:

• MOGAD: High-dose corticosteroids first-line; plasma exchange and IVIG for severe/refractory cases 2
• NMO (AQP4-positive): Biological agents represent first-line therapeutic strategy 3
• MS: Different disease-modifying therapy approach

Common Pitfalls to Avoid

1. Don't assume all optic neuritis is MS - the extraocular muscle involvement is a red flag that this is NOT typical MS-related optic neuritis
2. Don't delay antibody testing - waiting for clinical evolution wastes critical treatment time
3. Don't image orbits alone - always include brain MRI as pathologies frequently involve extraorbital structures 4
4. Don't miss the timing window - contrast enhancement is typically observable in the first 4-6 weeks of lesion formation 4

The presence of extraocular muscle enhancement alongside intracanalicular optic nerve involvement creates a signature pattern that strongly points toward MOGAD rather than classic MS-related optic neuritis.